Westlake Chemical (NYSE: WLK) reported Q4 EPS of $0.72, $0.18 worse than the analyst estimate of $0.90. Revenue for the quarter came in at $2.83 billion versus the consensus estimate of $2.86 billion.

For earnings history and earnings-related data on Westlake Chemical (WLK) click here.